378 Relevance of CT45 gene expression as a predictive biomarker in the recurrence of ovarian cancer
378 Relevance of CT45 gene expression as a predictive biomarker in the recurrence of ovarian cancer
About this item
Full title
Author / Creator
Publisher
Kidlington: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Introduction/BackgroundMost high-grade ovarian carcinomas (HGOCs) are sensitive to carboplatin (CBP)-based chemotherapy but frequently recur within 24 months. CT45 genes show oncogenic function. Coscia et al. (2018) studied CT45 as a significant marker of a positive response to chemotherapy. The aim of the study was to establish the relevance of CT...
Alternative Titles
Full title
378 Relevance of CT45 gene expression as a predictive biomarker in the recurrence of ovarian cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2954555644
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2954555644
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2024-ESGO.635
